Home › Targets › TARPγ8

TARPγ8 (1 companies · 7 programs)

Companies with an active program directed at TARPγ8.

Rapport Therapeutics, Inc. RAPP

  • RAP-219 — Focal Onset Seizures Phase 3
  • RAP-219 — Bipolar Mania Phase 2
  • RAP-219 Preclinical
  • RAP-219 — Primary Generalized Tonic-Clonic Seizures Phase 2
  • RAP-219 Phase 1
  • RAP-219 — Focal Onset Seizures Phase 1
  • RAP-219 — Focal Onset Seizures